Mucosis - Articles and news items

Mucosis’ needle-free nasal spray vaccine for RSV trial starts

Industry news / 8 November 2016 / Niamh Louise Marriott, Digital Content Producer

Mucosis has begun a first-in-human study of its intranasal Respiratory Syncytial Virus (RSV) vaccine candidate, SynGEM, at Imperial College London…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+